General Information of the Compound
Compound ID |
CP0444344
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
3-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-4-[(2S)-2-(phenoxymethyl)pyrrolidine-1-carbonyl]-1,2-dithia-5,8,11,14,17-pentazacycloicos-10-yl]propanamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C41H56N8O10S2
|
||||||||||||||||||
Molecular Weight |
885.079
|
||||||||||||||||||
Canonical SMILES |
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1COc1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C41H56N8O10S2/c1-3-24(2)36-40(57)45-29(15-16-33(42)51)37(54)46-31(21-34(43)52)38(55)47-32(41(58)49-18-7-8-26(49)22-59-28-9-5-4-6-10-28)23-61-60-19-17-35(53)44-30(39(56)48-36)20-25-11-13-27(50)14-12-25/h4-6,9-14,24,26,29-32,36,50H,3,7-8,15-23H2,1-2H3,(H2,42,51)(H2,43,52)(H,44,53)(H,45,57)(H,46,54)(H,47,55)(H,48,56)/t24-,26-,29-,30-,31-,32-,36-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
QAJZXWPTHMEYCS-CRPXVDIASA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound